| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Hopeaphenol |
Hopeaphenol |
388582-37-4 |
详细
|
| GW297361 |
化合物GW297361 |
388627-21-2 |
详细
|
| IW-927 |
化合物 T24185 |
389142-48-7 |
详细
|
| 1H-Isoindole-1,3(2H)-dione, 4-(2-aminoethoxy)-2-(2,6-dioxo-3-piperidinyl)- |
TQP0428 |
390367-50-7 |
详细
|
| Spliceostatin A |
司普利斯他汀A |
391611-36-2 |
详细
|
| VU0080241 |
化合物 T29121 |
393845-24-4 |
详细
|
| EBV lytic cycle inducer-1 |
3-溴-N'-(1-(吡啶-2-基)亚乙基)苯甲酰肼 |
394668-43-0 |
详细
|
| GSK-3/CDK5/CDK2-IN-1 |
GSK-3/CDK5/CDK2-IN-1 |
395074-72-3 |
详细
|
| Aselizumab |
阿塞珠单抗 |
395639-53-9 |
详细
|
| Picumast |
哌香豆司特 |
39577-19-0 |
详细
|
| Esprolol |
化合物 ESPROLOL |
396654-09-4 |
详细
|
| GLP-1R modulator C5 |
化合物 GLP-1R MODULATOR C5 |
421578-93-0 |
详细
|
| Corrector C4 |
CORRECTOR C4 |
421580-53-2 |
详细
|
| 2′,3′-Di-O-acetylguanosine |
|
42167-65-7 |
详细
|
| (-)-Phaselic acid |
(-)-Phaselic acid |
423170-79-0 |
详细
|
| CTX-0124143 |
CTX-0124143 |
423731-64-0 |
详细
|
| CCG-13514 |
化合物CCG-13514 |
423741-32-6 |
详细
|
| TPA-023B |
化合物 T13192 |
425377-76-0 |
详细
|
| Glycerophosphoinositol choline |
甘油磷酸肌醇胆碱盐 |
425642-32-6 |
详细
|
| Glycerophosphoinositol lysine |
甘油磷酸肌醇赖氨酸盐 |
425642-33-7 |
详细
|
| 1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl) |
化合物T67696 |
426242-86-6 |
详细
|
| Certolizumab pegol |
赛妥珠单抗 |
428863-50-7 |
详细
|
| EB1 |
化合物EB1 |
42951-68-8 |
详细
|
| Fluenetil |
FLUENETIL |
4301-50-2 |
详细
|
| MMRi64 |
化合物 T28078 |
430458-66-5 |
详细
|
| AMPK activator 12 |
AMPK 激活剂12 |
431920-24-0 |
详细
|
| WAY-639889 |
N-(9-乙基-9H-咔唑-3-基)-2-(4-吡啶-2-基)哌嗪-1-基)乙酰胺 |
432506-24-6 |
详细
|
| Lecozotan HCl |
Sra-333 |
433282-68-9 |
详细
|
| Atecegatran TFA |
阿特加群三氟乙酸盐 |
433937-75-8 |
详细
|
| beta-Thujaplicinol |
2,7-DIHYDROXY-4-ISOPROPYLCYCLOHEPTA-2,4,6-TRIEN-1-ONE |
4356-35-8 |
详细
|
| Nortopixantrone HCl |
化合物 T28189 |
438244-41-8 |
详细
|
| CP-810123 |
CP-810123 |
439608-12-5 |
详细
|
| DDRI-18 |
化合物 T23974 |
4402-18-0 |
详细
|
| PIH |
化合物 T24639 |
441742-93-4 |
详细
|
| FK-330 |
化合物 T31795 |
442198-67-6 |
详细
|
| ABT-510 acetate |
化合物 T24997 |
442526-87-6 |
详细
|
| CK2α-IN-1 |
3-((4-(3-硝基苯基)噻唑-2-基)氨基)苯甲酸 |
443747-52-2 |
详细
|
| SCH-336 |
化合物 T24771 |
447459-51-0 |
详细
|
| Topoisomerase II inhibitor 13 |
6-氨基-7-(1H-苯并[D]咪唑-2-基)-5-(3-(二乙基氨基)丙基)-5H-吡咯并[2,3-B]吡嗪-2,3-二甲腈 |
451515-89-2 |
详细
|
| BMS-488043 |
BMS 043 |
452296-83-2 |
详细
|
| AZD6538 |
3-Pyridinecarbonitrile, 6-[5-(3-cyano-5-fluorophenyl)-1,2,4-oxadiazol-3-yl]- |
453566-30-8 |
详细
|
| TSPO ligand-1 |
TSPO配体1 |
4560-08-1 |
详细
|
| ONO-8713 |
化合物 ONO-8713 |
459411-08-6 |
详细
|
| AVP-13358 |
2-[4-(金刚烷-1-基甲酰氨基)苯基]-N-(2-吡啶基)-1H-苯并咪唑-5-甲酰胺 |
459805-03-9 |
详细
|
| Aplaviroc hydrochloride |
Hydrochloride |
461023-63-2 |
详细
|
| IDO1/TDO-IN-4 |
化合物 IDO1/TDO-IN-4 |
461424-21-5 |
详细
|
| N-benzoyl-L-aspartic acid |
N-BENZOYL-ASPARTIC ACID |
4631-12-3 |
详细
|
| Elsilimomab |
伊斯利莫 |
468715-71-1 |
详细
|
| 1M6 |
1-methyl-6-nitro-2H-3,1-benzoxazine-2,4(1H)-dione |
4693-01-0 |
详细
|
| GW438014A |
GW 438014A;GW-438014A |
469861-49-2 |
详细
|
| IFB-088 acetate |
IFB-088 醋酸盐 |
469866-31-7 |
详细
|
| 5MPN |
5MPN |
47208-82-2 |
详细
|
| Carpinontriol B |
CARPINONTRIOL B |
473451-73-9 |
详细
|
| LSD1-IN-24 |
LSD抑制剂24 |
4734-59-2 |
详细
|
| MM0299 |
化合物 MM0299 |
474255-10-2 |
详细
|
| Fmoc-MMAE |
((S)-1 - ((S)-1 - (((3R,4S,5S)-1 - ((S)-2 - ((1R,2 |
474645-26-6 |
详细
|
| Musellarin A |
MUSELLARIN A |
477565-36-9 |
详细
|
| GGTI-2154 hydrochloride |
化合物 GGTI-2154 HYDROCHLORIDE |
478908-50-8 |
详细
|
| IK-862 |
化合物 T27592 |
478911-60-3 |
详细
|
| broparestrol |
溴帕雌烯 |
479-68-5 |
详细
|
| Diaplasinin |
DIAPLASININ |
481631-45-2 |
详细
|
| Denagliptin |
地格列汀 |
483369-58-0 |
详细
|
| β-Glucuronidase-IN-1 |
1-((6,8-dimethyl-2-oxo-1,2-dihydroquinolin-3-yl)methyl)-3-(4-ethoxyphenyl)-1-(2-hydroxyethyl)thiourea |
484006-66-8 |
详细
|
| FAK-IN-10 |
WAY-320461 |
491839-65-7 |
详细
|
| PDCD4-IN-1 |
化合物PDCD4-IN-1 |
494763-64-3 |
详细
|
| Penflufen |
氟唑菌苯胺 |
494793-67-8 |
详细
|
| Egis-11150 |
化合物 T27248 |
494861-87-9 |
详细
|
| Androstane-3,6,17-triol |
(3S,5S,6S,8R,9S,10R,13S,14S,17S)-10,13-二甲基六氢十氢-1H- |
49644-04-4 |
详细
|
| Drupacine |
桥氧三尖杉碱 |
49686-57-9 |
详细
|
| Pritumumab |
普托木单抗 |
499212-74-7 |
详细
|
| Picarbutrazox |
叔丁基N-[6-[[((Z)-[(1-甲基四唑-5-基)苯基亚甲基]氨基]氧甲基]-2-吡啶基]氨基甲酸酯 |
500207-04-5 |
详细
|
| 2-benzylsulfanyl-6-methoxy-4-methylquinazoline |
WAY-325104 |
500272-00-4 |
详细
|
| MK-0873 |
MK0873 |
500355-52-2 |
详细
|
| Quorum Sensing-IN-3 |
QUORUM SENSING抑制剂1 |
5005-14-1 |
详细
|
| NSC61610 |
1-N,4-N-bis[3-(1H-benzimidazol-2-yl)phenyl]benzene-1,4-dicarboxamide |
500538-94-3 |
详细
|
| Delmitide acetate |
RDP-58 ACETATE |
501019-16-5 |
详细
|
| N-[(4-methylphenyl)carbamothioyl]-2-nitrobenzamide |
N-[[(4-甲基苯基)氨基]硫氧甲基]-2-硝基苯甲酰胺 |
501105-47-1 |
详细
|
| TIE-2/VEGFR-2 kinase-IN-2 |
|
501693-48-7 |
详细
|
| 23-epi-26-Deoxyactein |
23-表-26-去羟基阿科特素 |
501938-01-8 |
详细
|
| Cantuzumab mertansine |
cantuzumab mertansine |
400010-39-1 |
详细
|
| Erucifoline |
芝麻菜叶千里光碱 |
40158-95-0 |
详细
|
| Celivarone |
Celivarone |
401925-43-7 |
详细
|
| WAY-297848 |
2-(4-氯苯氧基)-2-甲基-N-(噻唑-2-基)丙酰胺 |
404360-27-6 |
详细
|
| Flurocitabine HCl |
氟西他滨盐酸盐 |
40505-45-1 |
详细
|
| Bufotenidine hydrochloride(487-91-2 Free base) |
盐酸蟾蜍特尼定 |
40581-89-3 |
详细
|
| GW6340 |
化合物 GW6340 |
405910-78-3 |
详细
|
| BCAT-IN-4 |
BCAT抑制剂4 |
406190-85-0 |
详细
|
| ANO1-IN-1 |
化合物 ANO1-IN-1 |
407587-01-3 |
详细
|
| Flucetosulfuron |
氟吡磺隆 |
412928-75-7 |
详细
|
| Goxalapladib |
2-[2-(2,3-二氟苯基)乙基]-N-[1-(2-甲氧基乙基)-4-哌啶基]-4-氧代-N-[[4'-(三氟甲基)[1,1'-联苯]-4-基]甲基]-1,8-萘啶-1(4H)-乙酰胺 |
412950-27-7 |
详细
|
| ESP-31015 |
化合物 T31677 |
413624-55-2 |
详细
|
| Bleomycin A2 |
(3-(2'-(1-(6-氨基-2-(3-氨基-1-((2,3-二氨基-3-氧代丙基)氨基)-3-氧代丙基)-5-甲基嘧啶-4-基)-3-((((2R,3S,4S,5S,6S)-3-(((2R,3S, |
41432-97-7 |
详细
|
| RDR 02308 |
化合物 RDR 02308 |
4155-82-2 |
详细
|
| GPR30 agonist-1 |
GPR30 AGONIST-1 |
415919-74-3 |
详细
|
| LM-1685 |
化合物 T32824 |
416901-58-1 |
详细
|
| Transketolase-IN-4 |
5-苄基-3-(4-氯苯基)吡唑并[1,5-A]嘧啶-7(4H)-酮 |
419547-73-2 |
详细
|
| Nafetolol |
萘非洛尔 |
42050-23-7 |
详细
|
| Amorphigenin |
|
4208-09-7 |
详细
|
| Etilefrine pivalate HCl |
匹伐依替福林盐酸盐 |
42145-91-5 |
详细
|
| p38 MAP Kinase Inhibitor Ⅵ |
2-((5,6-二甲基噻吩并[2,3-D]嘧啶-4-基)硫基)-1-(4-氟苯基)乙酮 |
421578-46-3 |
详细
|